Keywords: abbott, cuts, earnings, forecasts, plant, woes, lower

Abbott cuts earnings forecasts on plant woes and lower Meridia/Reductil sales

Article | 17 June 2002

Print This

US drugs major Abbott Laboratories has issued a revised earningsguidance, reflecting the impact of the company's consent decree with the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in